alexa High-throughput screening, metabolomics and drug discovery.


Journal of Drug Metabolism & Toxicology

Author(s): Harrigan GG, Yates LA, Harrigan GG, Yates LA

Abstract Share this page

Abstract The science of metabolomics has the potential to deliver wide-reaching benefits to the currently embattled pharmaceutical industry. Current applications for this field center around toxicological profiling and biomarker studies; however, the ability of metabolomics to quantitatively assess pharmacologically induced changes in biological systems at the phenotype level suggests that there would be value in its adoption at much earlier phases of the drug-discovery process. As is argued herein, this approach could be coupled with a re-organization of early drug-discovery paradigms to reduce both the rates of attrition and the costs of bringing a drug to market.
This article was published in IDrugs and referenced in Journal of Drug Metabolism & Toxicology

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version